← Back to Search

Experimental Group 2 for Chronic Lower Back Pain (VIGOR Trial)

N/A
Waitlist Available
Led By James S Thomas, P.T., Ph.D.
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline 1-, 6-, 12-, 24-, and 48-weeks post-treatment
Awards & highlights

VIGOR Trial Summary

This trial will explore whether playing video games can help people with chronic low back pain by improving their movement.

Eligible Conditions
  • Chronic Lower Back Pain
  • Atychiphobia
  • Injury Phobia

VIGOR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline 1-, 6-, 12-, 24-, and 48-weeks post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline 1-, 6-, 12-, 24-, and 48-weeks post-treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Disability
Change in Pain
Secondary outcome measures
Change in Lumbar Spine Flexion
Change in Pain & Harm Expectancy
Change in Real World Activity
Other outcome measures
Change in Emotional Functioning
Change in Pain Interference with Physical Function
Change in Pain Resilience
+3 more

VIGOR Trial Design

2Treatment groups
Experimental Treatment
Group I: Experimental Group 2Experimental Treatment1 Intervention
Participants will produce progressively larger lumbar flexion excursions at each game level and across treatment sessions.
Group II: Experimental Group 1Experimental Treatment1 Intervention
Participants will produce progressively larger lumbar flexion excursions at each game level and across treatment sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Experimental Group 1
2019
N/A
~160
Experimental Group 2
2019
N/A
~160

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,977 Previous Clinical Trials
2,680,638 Total Patients Enrolled
Virginia Commonwealth UniversityLead Sponsor
700 Previous Clinical Trials
22,886,614 Total Patients Enrolled
Ohio UniversityOTHER
70 Previous Clinical Trials
37,079 Total Patients Enrolled

Media Library

Experimental Group 1 Clinical Trial Eligibility Overview. Trial Name: NCT03463824 — N/A
Chronic Lower Back Pain Research Study Groups: Experimental Group 1, Experimental Group 2
Chronic Lower Back Pain Clinical Trial 2023: Experimental Group 1 Highlights & Side Effects. Trial Name: NCT03463824 — N/A
Experimental Group 1 2023 Treatment Timeline for Medical Study. Trial Name: NCT03463824 — N/A
Chronic Lower Back Pain Patient Testimony for trial: Trial Name: NCT03463824 — N/A
~25 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top